PharmaSphere Consulting ApS: Financial statements 2017
CVR: 36696222
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PharmaSphere Consulting ApS (CVR 36696222) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 263,802 and a net result of DKK 73,421 compared with DKK -87,695 the year before. That is an increase of 707% compared with the year before. Equity in the 2017 report amounted to DKK 181,674. The solvency ratio was 38.5%.
- Gross Profit
- DKK 263,802
- Profit/Loss
- DKK 73,421
- Equity
- DKK 181,674
- Total Assets
- DKK 472,352
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 264 t. | 73 t. | 182 t. | - |
| 2016 | - | 33 t. | -88 t. | 258 t. | - |
Official annual report
Keep an eye on PharmaSphere Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PharmaSphere Consulting ApS has published its annual report for 2016. Gross profit came to DKK 32,690, and the net result was DKK -87,695.
About PharmaSphere Consulting ApS
PharmaSphere Consulting ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Søren Graves Truelsen. The company is owned by STruelsen-Holding ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 2,479,823 and a net result of DKK 321,621 compared with DKK 688,490 the year before. Equity in the 2025 report amounted to DKK 466,582.